[vc_row][vc_column][vc_column_text]Most hospitals say the same things in their marketing:<\/p>\n
\u201cWe\u2019re leaders in quality.\u201d<\/p>\n
\u201cWorld-class care.\u201d<\/p>\n
\u201cClinical excellence.\u201d<\/p>\n
The problem isn\u2019t that it\u2019s false. The problem is that it\u2019s invisible.<\/strong> In fact, there\u2019s evidence that patient-experience data (like HCAHPS) and narrative The executive-level question is simple:<\/p>\n [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n Healthcare marketing isn\u2019t like selling sneakers. There\u2019s a red line: you can\u2019t Translation for marketing + leadership: <\/strong>if you want to say \u201cour infection rate is \u201cQuality\u201d becomes powerful when it turns into a verifiable promise, for example:<\/p>\n AHRQ maintains indicator sets (Quality Indicators \/ Patient Safety Indicators) that CMS also publishes patient-experience results (HCAHPS) publicly through Care Compare.<\/strong> (CMS<\/a>)[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n Claims that work (and are defensible)<\/strong><\/p>\n As long as you provide context and substantiation:<\/p>\n CMS uses HAI measures derived from NHSN (CDC), including colon surgery and Claims that are legal + reputational landmines<\/strong><\/p>\n [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n 1) Define your \u201coutcome offer\u201d <\/strong><\/p>\n 2) Choose 3\u20135 metrics that matter to patients and payers<\/strong> 3) Standardize definitions (so this isn\u2019t \u201ccreative marketing\u201d)<\/strong><\/p>\n For infections, for instance, surveillance commonly uses constructs like the SIR 4) Turn metrics into stories (without manipulating)<\/strong><\/p>\n Patients don\u2019t buy an \u201cSIR.\u201d They buy peace of mind. 5) Publish with operational transparency<\/strong><\/p>\n Always include:<\/p>\n [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n If you use clinical data in public communication, two golden rules apply:<\/p>\n Don\u2019t use PHI in marketing without a legal basis\/authorization<\/strong> [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n This is where a HIS stops being \u201cdocumentation software\u201d and becomes a commercial + reputational engine.<\/strong><\/p>\n 1) Clinical BI that marketing can actually defend<\/strong> Its clinical modules also reference reports and statistics<\/strong> for analysis and continuous improvement. (Harmoni MD<\/a>)<\/p>\n In practice, this enables you to:<\/p>\n 2) CLARA: less friction turning data into clear messaging<\/strong> That accelerates the bridge from \u201coperations \u2192 evidence \u2192 communication,\u201d In 2026, winning hospital marketing isn\u2019t the loudest \u201cwe\u2019re excellent.\u201d It\u2019s the one that explains: <\/p>\n That\u2019s ethical. That\u2019s defensible. And it converts because trust has ROI. <\/p>\n If you want to see how HarmoniMD (HIS) + CLARA<\/a> can help you transform [vc_row][vc_column][vc_column_text]Most hospitals say the same things in their marketing: \u201cWe\u2019re leaders in quality.\u201d \u201cWorld-class care.\u201d \u201cClinical excellence.\u201d The problem isn\u2019t that it\u2019s false. The problem is that it\u2019s invisible. In 2026, \u201cquality\u201d as an abstract concept doesn\u2019t compete against: public comparisons, reviews, social narratives, and metrics that can actually be measured. In fact, there\u2019s evidence […]<\/p>\n","protected":false},"author":1,"featured_media":8290,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"Healthcare marketing based on real clinical data","_seopress_titles_desc":"Learn how to use real clinical data to attract patients without legal risks. Evidence-based, ethical, and results-oriented healthcare marketing. ","_seopress_robots_index":"","footnotes":""},"categories":[178],"tags":[],"class_list":["post-8292","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-marketing"],"_links":{"self":[{"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/posts\/8292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/comments?post=8292"}],"version-history":[{"count":0,"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/posts\/8292\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/media\/8290"}],"wp:attachment":[{"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/media?parent=8292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/categories?post=8292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/harmonimd.com\/en\/wp-json\/wp\/v2\/tags?post=8292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nIn 2026, \u201cquality\u201d as an abstract concept doesn\u2019t compete against: <\/p>\n\n
stories (\u201cthey treated me terribly\u201d \/ \u201cthey saved my life\u201d) can influence hospital
choice in comparable ways. (PubMed<\/a>)<\/p>\nAre you selling \u201cpromises\u201d\u2026 or are you selling \u201cresults\u201d?<\/h5>\n
The angle: ethical healthcare marketing (no hype, no \u201cmiracles,\u201d no unsupported claims)<\/h4>\n
imply guaranteed outcomes, exaggerate, or hide material conditions.<\/strong> <\/p>\n\n
materially misleading; and objective claims about quality should only be
made if they are factually supportable. (code-medical-ethics.ama-
assn.org) <\/li>\n
\nobjective claims must be substantiated before you publish them.
(Federal Trade Commission) <\/li>\n<\/ul>\n
exceptionally low,\u201d great\u2014but back it with methodology, time period, denominator,
and evidence.<\/p>\nThe thesis: stop selling \u201cquality.\u201d Sell results (clearly and responsibly) <\/h4>\n
\n
have been considered suitable for consumer-oriented reporting.<\/strong> (ahrq.gov<\/a>)<\/p>\nWhat you can say (and what you should avoid)<\/h4>\n
\n
during [Q1\u2013Q4 2026].\u201d<\/li>\n
[Range] based on a standardized survey.\u201d<\/li>\n<\/ul>\n
hysterectomy SSI measures, within measurement programs. (CMS<\/a>)<\/p>\n\n
warns testimonials can be misleading if they don\u2019t represent typical results).
(code-medical-ethics.ama-assn.org<\/a>)<\/li>\n<\/ul>\nThe framework: Evidence-Based Marketing (EBMKT) in 5 steps<\/h4>\n
\n
\nExamples (select based on your service lines and reality):<\/p>\n\n
(Standardized Infection Ratio) in NHSN methodology\u2014observed vs expected,
adjusted for risk. (Salud P\u00fablica SC<\/a>)<\/p>\n
\nA responsible narrative looks like: <\/p>\n\n
case.\u201d<\/li>\n\n
This doesn\u2019t weaken your marketing. It makes it credible.<\/h5>\n
The sensitive part: privacy and data use (so you don\u2019t create a compliance
problem)<\/h4>\n
\nHHS explains that \u201cmarketing\u201d under HIPAA often requires authorization if
it involves PHI, with specific exceptions. (HHS.gov<\/a>)
\nWhen publishing outcomes, publish aggregated or de-identified data<\/strong>
Regulations (45 CFR 164.514) describe de-identification methods,
including Safe Harbor (removing identifiers) or expert determination. (LII<\/a>)<\/p>\nQuick compliance-friendly checklist:<\/h5>\n
\n
Where HarmoniMD fits: from \u201clocked data\u201d to evidence-based campaigns<\/h4>\n
\nHarmoniMD describes data-driven decision-making via reports and visualizations<\/strong> to identify trends and projections. (Harmoni MD<\/a>)<\/p>\n\n
\nCLARA is presented as an integrated assistant capable of analyzing charts, summarizing clinical information, and supporting report writing for clinician review and sign-off. (Harmoni MD<\/a>)<\/p>\n
without making clinicians feel like marketing is stealing their time.<\/p>\nConclusion: OR schedules don\u2019t fill with slogans\u2014they fill with verifiable trust<\/h5>\n
\n
\nclinical records into actionable Business Intelligence<\/strong> (for quality, operations\u2026
and evidence-based marketing), book a demo.<\/a> We\u2019ll review your priority service
lines, your current indicators, and a roadmap to publish outcomes with rigor, clarity,
and compliance. [\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"